ClinicalTrials.govpublic full text
Compassionate Use Study of Tenalisib (RP6530)
hematological malignancies, tenalisib, rp6530, compassionate use, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912687
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.